Abstract

The systemic capillary leak syndrome (SCLS, Clarkson disease) is a disorder of unknown etiology characterized by recurrent episodes of vascular leakage of proteins and fluids into peripheral tissues, resulting in whole-body edema and hypotensive shock. The pathologic mechanisms and genetic basis for SCLS remain elusive. Here we identify an inbred mouse strain, SJL, which recapitulates cardinal features of SCLS, including susceptibility to histamine- and infection-triggered vascular leak. We named this trait “Histamine hypersensitivity” (Histh/Histh) and mapped it to Chromosome 6. Histh is syntenic to the genomic locus most strongly associated with SCLS in humans (3p25.3), revealing that the predisposition to develop vascular hyperpermeability has a strong genetic component conserved between humans and mice and providing a naturally occurring animal model for SCLS. Genetic analysis of Histh may reveal orthologous candidate genes that contribute not only to SCLS, but also to normal and dysregulated mechanisms underlying vascular barrier function more generally.

Raza et al. report a naturally occurring animal model that recapitulates cardinal features of Systemic Capillary Leak Syndrome and map its histamine-triggered vascular leak trait to Chromosome 6. They suggest that the predisposition to develop vascular hyperpermeability has a strong genetic component conserved between humans and mice.

Details

Title
A natural mouse model reveals genetic determinants of systemic capillary leak syndrome (Clarkson disease)
Author
Raza Abbas 1 ; Xie Zhihui 2 ; Chan, Eunice C 2 ; Wei-Sheng, Chen 2 ; Scott, Linda M 2 ; Robin, Eisch A 2 ; Krementsov, Dimitry N 3 ; Rosenberg, Helene F 4 ; Parikh, Samir M 5   VIAFID ORCID Logo  ; Blankenhorn, Elizabeth P 6 ; Teuscher Cory 1 ; Druey, Kirk M 2 

 Departments of Medicine and Pathology, University of Vermont School of Medicine, Burlington, USA (GRID:grid.59062.38) (ISNI:0000 0004 1936 7689) 
 Lung and Vascular Inflammation Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, USA (GRID:grid.59062.38) 
 Department of Biomedical and Health Sciences, University of Vermont School of Medicine, Burlington, USA (GRID:grid.59062.38) (ISNI:0000 0004 1936 7689) 
 Inflammation Immunobiology Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, USA (GRID:grid.59062.38) 
 Division of Nephrology and Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X) 
 Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, USA (GRID:grid.166341.7) (ISNI:0000 0001 2181 3113) 
Publication year
2019
Publication date
2019
Publisher
Nature Publishing Group
e-ISSN
23993642
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2389678151
Copyright
© This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.